Pericardial fat is associated with ventricular tachyarrhythmia andmortality in patients with systolic heart failure

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 607-614

  Wu, Cho Kai ^a   Tsai, Hao Yuan ^b   Su, Mao Yuan M ^a   Wu, Yi Fan ^c   Hwang, Juey Jen ^a   Tseng, Wen Yih ^a   Lin, Jiunn Lee ^a   Lin, Lian Yu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Adipose tissue; Magnetic resonance imaging; Pericardial fat; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ADIPOSE TISSUE; ADULT; ARTICLE; BODY SURFACE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PERICARDIAL FAT; PERICARDIAL FAT VOLUME; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SYSTOLIC HEART FAILURE; AGED; BODY MASS; FACTUAL DATABASE; HEART VENTRICLE; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PERICARDIUM; RISK FACTOR; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADIPOSITY; AGED; BODY MASS INDEX; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERICARDIUM; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84935029203     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.025     Document Type: Article

References (43)

1. Lloyd-Jones D.M., Larson M.G., Leip E.P., et al. Lifetime risk for developing congestive heart failure: the Framingham heart Study. Circulation 2002, 106:3068-3072.
2. Roger V.L. Epidemiology of heart failure. Circ. Res. 2013, 113:646-659.
3. Ho E., Shimada Y. Formation of the epicardium studied with the scanning electron microscope. Dev. Biol. 1978, 66:579-585.
4. Sacks H.S., Fain J.N. Human epicardial adipose tissue: a review. Am. Heart J. 2007, 153:907-917.
5. Nelson A.J., Worthley M.I., Psaltis P.J., et al. Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J.Cardiovasc Magn. Reson 2009, 11:15.
6. Doesch C., Haghi D., Fluchter S., et al. Epicardial adipose tissue in patients with heart failure. J.Cardiovasc Magn. Reson 2010, 12:40.
7. Kankaanpaa M., Lehto H.R., Parkka J.P., et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J.Clin. Endocrinol. Metab. 2006, 91:4689-4695.
8. Thanassoulis G., Massaro J.M., O'Donnell C.J., et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham heart Study. Circ. Arrhythm. Electrophysiol. 2010, 3:345-350.
9. Wong C.X., Abed H.S., Molaee P., et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J.Am. Coll. Cardiol. 2011, 57:1745-1751.
10. Corradi D., Maestri R., Callegari S., et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol. 2004, 13:313-316.
11. Iacobellis G., Ribaudo M.C., Assael F., et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J.Clin. Endocrinol. Metab. 2003, 88:5163-5168.
12. Shirani J., Berezowski K., Roberts W.C. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am. J. Cardiol. 1995, 76:414-418.
13. Lin L.Y., Su M.Y., Chen J.J., et al. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure. JACC Cardiovasc Imaging 2013, 6:1152-1159.
14. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
15. Kellman P., Arai A.E., McVeigh E.R., et al. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn. Reson Med. 2002, 47:372-383.
16. Huber A.M., Schoenberg S.O., Hayes C., et al. Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction. Radiology 2005, 237:854-860.
17. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114:32-39.
18. Tseng W.Y., Liao T.Y., Wang J.L. Normal systolic and diastolic functions of the left ventricle and left atrium by cine magnetic resonance imaging. J.Cardiovasc Magn. Reson 2002, 4:443-457.
19. Issac T.T., Dokainish H., Lakkis N.M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J.Am. Coll. Cardiol. 2007, 50:2021-2028.
20. Pietrasik G., Goldenberg I., McNitt S., et al. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients. J.Cardiovasc Electrophysiol. 2007, 18:181-184.
21. Mazurek T., Zhang L., Zalewski A., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
22. Blangy H., Sadoul N., Dousset B., et al. Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace 2007, 9:724-729.
23. Nguyen B.L., Fishbein M.C., Chen L.S., et al. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm. 2009, 6:454-460.
24. Pouliopoulos J., Chik W.W., Kanthan A., et al. Intramyocardial adiposity after myocardial infarction: new implications of a substrate for ventricular tachycardia. Circulation 2013, 128:2296-2308.
25. Rabkin S.W. Epicardial fat: properties, function and relationship to obesity. Obes. Rev. 2007, 8:253-261.
26. Tsao H.M., Hu W.C., Wu M.H., et al. Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation. Am. J. Cardiol. 2011, 107:1498-1503.
27. Levi-Montalcini R. Effects of mouse tumor transplantation on the nervous system. Ann. N. Y. Acad. Sci. 1952, 55:330-344.
28. Chaldakov G.N., Fiore M., Stankulov I.S., et al. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?. Prog. Brain Res. 2004, 146:279-289.
29. La Rovere M.T., Bigger J.T., Marcus F.I., et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic tone and reflexes after myocardial Infarction) Investigators. Lancet 1998, 351:478-484.
30. Pruvot E., Thonet G., Vesin J.M., et al. Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation 2000, 101:2398-2404.
31. Lin H.H., Lee J.K., Yang C.Y., et al. Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis. Cardiovasc Diabetol. 2013, 12:127.
32. Iacobellis G., Ribaudo M.C., Zappaterreno A., et al. Relation between epicardial adipose tissue and left ventricular mass. Am. J. Cardiol. 2004, 94:1084-1087.
33. Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care 2011, 34(Suppl.2):S371-S379.
34. Greenstein A.S., Khavandi K., Withers S.B., et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009, 119:1661-1670.
35. Henrichot E., Juge-Aubry C.E., Pernin A., et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2594-2599.
36. Iozzo P., Lautamaki R., Borra R., et al. Contribution of glucose tolerance and gender to cardiac adiposity. J.Clin. Endocrinol. Metab. 2009, 94:4472-4482.
37. Rosito G.A., Massaro J.M., Hoffmann U., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham heart Study. Circulation 2008, 117:605-613.
38. Taguchi R., Takasu J., Itani Y., et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 2001, 157:203-209.
39. Hirata Y., Kurobe H., Akaike M., et al. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int. Heart J. 2011, 52:139-142.
40. Hirata Y., Tabata M., Kurobe H., et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J.Am. Coll. Cardiol. 2011, 58:248-255.
41. Khawaja T., Greer C., Chokshi A., et al. Epicardial fat volume in patients with left ventricular systolic dysfunction. Am. J. Cardiol. 2011, 108:397-401.
42. Whayne T.F. Epicardial fat thickness in heart failure and other clinical conditions. Angiology 2013, 64:169-172.
43. Iacobellis G., Zaki M.C., Garcia D., et al. Epicardial fat in atrial fibrillation and heart failure. Horm. Metab. Res. 2014, 46:587-590.